Synapse Open Synapse
Biology

Revolution’s Rasonque off to best cancer drug launch ‘in history’

BioPharma Dive · · 2 min read

Wall Street analysts are already resetting projections for Rasonque — but company executives cautioned that it’s too early to draw conclusions about the pancreatic cancer drug’s launch trajectory.

Latest from BioPharma Dive